Antianginal agents is a term used to describe a wide variety of medicines that are used in the management of angina.
This report contains market size and forecasts of Antianginal Agents in global, including the following market information:
Global Antianginal Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antianginal Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antianginal Agents companies in 2021 (%)
The global Antianginal Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nitrates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antianginal Agents include Teva, Merck, Pfizer, Mylan N.V., Elite Pharmaceutical Solution Inc., Pharmaoffer.com, AstraZeneca, ACETO and Nesher Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antianginal Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antianginal Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antianginal Agents Market Segment Percentages, by Type, 2021 (%)
Nitrates
Beta Blockers
Calcium Channel Blockers
Global Antianginal Agents Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antianginal Agents Market Segment Percentages, by Distribution Channel, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Antianginal Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antianginal Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antianginal Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antianginal Agents revenues share in global market, 2021 (%)
Key companies Antianginal Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antianginal Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Merck
Pfizer
Mylan N.V.
Elite Pharmaceutical Solution Inc.
Pharmaoffer.com
AstraZeneca
ACETO
Nesher Pharmaceuticals
Taj pharmaceutical
Espero BioPharma
Hikma Pharmaceuticals
Athenex
Aurobindo Pharma
AMRI
Intas Pharmaceuticals
Glenmark Pharmaceuticals
Troikaa
Square Pharmaceuticals
Sun Pharmaceutical
Unique Pharmaceuticals
Ipca Laboratories
Sandoz
Globus Remedies
Shandong Fangming Pharmaceutical Group
ReYoung Pharmaceutical